A detailed history of Summit Trail Advisors, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Summit Trail Advisors, LLC holds 13,711 shares of EW stock, worth $1.27 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
13,711
Previous 13,522 1.4%
Holding current value
$1.27 Million
Previous $1.03 Million 27.06%
% of portfolio
0.04%
Previous 0.03%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

BUY
$72.54 - $95.56 $13,710 - $18,060
189 Added 1.4%
13,711 $1.31 Million
Q4 2023

Feb 06, 2024

BUY
$61.71 - $77.76 $11,848 - $14,929
192 Added 1.44%
13,522 $1.03 Million
Q3 2023

Oct 30, 2023

BUY
$69.28 - $93.38 $923,502 - $1.24 Million
13,330 New
13,330 $923,000
Q1 2023

May 04, 2023

BUY
$74.26 - $84.51 $48,788 - $55,523
657 Added 22.63%
3,560 $294,000
Q4 2022

Feb 07, 2023

BUY
$68.3 - $87.44 $198,274 - $253,838
2,903 New
2,903 $216,000
Q2 2022

Aug 09, 2022

BUY
$86.5 - $128.27 $216,336 - $320,803
2,501 New
2,501 $238,000
Q1 2022

May 16, 2022

SELL
$101.96 - $128.34 $289,260 - $364,100
-2,837 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$106.37 - $130.68 $33,081 - $40,641
311 Added 12.31%
2,837 $368,000
Q3 2021

Nov 16, 2021

BUY
$102.91 - $122.75 $16,877 - $20,131
164 Added 6.94%
2,526 $286,000
Q2 2021

Aug 16, 2021

BUY
$83.84 - $104.76 $198,030 - $247,443
2,362 New
2,362 $245,000
Q4 2020

Feb 16, 2021

SELL
$71.69 - $91.23 $188,616 - $240,026
-2,631 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$67.19 - $87.44 $6.49 Million - $8.45 Million
-96,636 Reduced 97.35%
2,631 $211,000
Q1 2018

May 21, 2018

BUY
$37.19 - $47.45 $3.67 Million - $4.68 Million
98,568 Added 14101.29%
99,267 $99,000
Q4 2017

Feb 14, 2018

BUY
$33.79 - $39.39 $23,619 - $27,533
699
699 $86,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $57.1B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Summit Trail Advisors, LLC Portfolio

Follow Summit Trail Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Trail Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Trail Advisors, LLC with notifications on news.